Distinct mechanisms of interferon-gamma and tumor necrosis factor-alpha action in oncogene-transformed mouse

B Seliger1, M Killian, K Pfizenmaier

  • 1Max-Planck-Society, Medical Clinic of the University of Göttingen, Federal Republic of Germany.

Insights

Interferon-gamma and tumor necrosis factor-alpha inhibit tumor cell growth and restore major histocompatibility complex (MHC) class I expression. These cytokines differentially modulate oncogene expression, impacting tumor cell phenotypes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Tumor cells often suppress major histocompatibility complex (MHC) class I antigen expression, evading immune detection.
  • Interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) are key cytokines involved in immune responses and cancer surveillance.
  • Understanding how these cytokines affect tumor cells is crucial for developing effective cancer immunotherapies.

Purpose of the Study:

  • To investigate the mechanisms by which IFN-γ and TNF-α influence tumor cell growth and MHC class I expression.
  • To elucidate the differential effects of these cytokines on oncogene expression in transformed cells.

Main Methods:

  • Utilized a mouse fibroblast model transformed with retroviral vectors encoding v-mos, c-myc, or v-Ha-ras oncogenes.
  • Treated transformed cells with IFN-γ and TNF-α.
  • Assessed cell growth, MHC class I antigen expression, and oncogene expression (including LTR-driven activity and RNA stability).
  • Measured CAT activity in LTR-CAT transformants to evaluate promoter activity.

Main Results:

  • Both IFN-γ and TNF-α inhibited the growth of v-mos and c-myc transformed cells.
  • Treatment with both cytokines reversed the suppression of MHC class I antigen expression in all transformed cell lines.
  • TNF-α primarily affected the stability of oncogene-specific RNAs.
  • IFN-γ acted at the transcriptional level, inhibiting LTR activity, particularly Moloney-virus-derived promoters.

Conclusions:

  • IFN-γ and TNF-α can revert oncogene-induced suppression of MHC class I expression, enhancing anti-tumor immunity.
  • The cytokines exhibit distinct mechanisms: TNF-α impacts RNA stability, while IFN-γ modulates transcriptional activity of specific retroviral promoters.
  • These findings highlight the complex interplay between cytokines and oncogene expression in tumor cells.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...